Search

Zimmer Biomet Holdings Inc

Abrir

SetorSaúde

95.59 -0.94

Visão Geral

Variação de preço das ações

24h

Atual

Mín

94.16

Máximo

96.98

Indicadores-chave

By Trading Economics

Rendimento

99M

239M

Vendas

-157M

2.1B

P/E

Médio do Setor

23.852

64.641

EPS

2.09

Rendimento de Dividendos

1.05

Margem de lucro

11.43

Funcionários

17,000

EBITDA

84M

538M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+2.66% upside

Dividendos

By Acuity

Rendimento de Dividendos

Médio do Setor

1.05%

2.31%

Próximos Ganhos

5 de ago. de 2026

Próxima data de dividendos

30 de out. de 2026

Próxima data de ex-dividendo

29 de set. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-110M

18B

Abertura anterior

96.53

Fecho anterior

95.59

Sentimento de Notícias

By Acuity

31%

69%

97 / 340 Ranking em Healthcare

Zimmer Biomet Holdings Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de ago. de 2026, 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31 de jul. de 2026, 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30 de jul. de 2026, 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29 de jul. de 2026, 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28 de jul. de 2026, 20:03 UTC

News
Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27 de jul. de 2026, 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24 de jul. de 2026, 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23 de jul. de 2026, 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22 de jul. de 2026, 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20 de jul. de 2026, 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Comparação entre Pares

Variação de preço

Zimmer Biomet Holdings Inc Previsão

Preço-alvo

By TipRanks

2.66% parte superior

Previsão para 12 meses

Média 99.56 USD  2.66%

Máximo 115 USD

Mínimo 83 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Zimmer Biomet Holdings Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

10 ratings

4

Comprar

6

Manter

0

Vender

Sentimento

By Acuity

97 / 340 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat